# APrevent Vocal Implant System (VOIS) for Adjustable Treatment of Unilateral Vocal Fold Paralysis (UVFP)

> **NCT03864757** · NA · COMPLETED · sponsor: **APrevent Biotech GmbH** · enrollment: 8 (actual)

## Conditions studied

- Paralysis, Unilateral, Vocal Cord

## Interventions

- **DEVICE:** thyroplasty implant

## Key facts

- **NCT ID:** NCT03864757
- **Lead sponsor:** APrevent Biotech GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-05
- **Primary completion:** 2019-02-21
- **Final completion:** 2019-02-21
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03864757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03864757, "APrevent Vocal Implant System (VOIS) for Adjustable Treatment of Unilateral Vocal Fold Paralysis (UVFP)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03864757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*